 |
 |

Familiality of Novel Factorial Dimensions of Schizophrenia
John A. McGrath, MA;
Dimitrios Avramopoulos, MD, PhD;
Virginia K. Lasseter, BA;
Paula S. Wolyniec, MA;
M. Daniele Fallin, PhD;
Kung-Yee Liang, PhD;
Gerald Nestadt, MD;
Mary H. Thornquist, PhD;
James R. Luke, PsyD;
Pei-Lung Chen, MD;
David Valle, MD;
Ann E. Pulver, ScD
Arch Gen Psychiatry. 2009;66(6):591-600. doi:10.1001/archgenpsychiatry.2009.56
ABSTRACT
Context Factor analysis of the signs and symptoms of schizophrenia yields dimensional phenotypes that may relate to underlying genetic variation. Examination of familiality of factor scores can demonstrate whether they are likely to be of use in genetic research.
Objective To produce a broader set of factorial phenotypes that are tested for familiality including core symptoms of schizophrenia and additional indicators of social, work, and educational dysfunction.
Design The study used psychiatric assessment data collected from several large samples of individuals with schizophrenia who have participated in family or case-control genetic studies (1988-2006) in the Epidemiology-Genetics Program in Psychiatry, The Johns Hopkins University School of Medicine, Baltimore, Maryland. Seventy-three signs and symptoms were selected from direct assessment interviews and consensus diagnostic ratings (integrating interview data, medical records, and informant reports).
Setting Study participants were recruited from across the United States, and a few additional participants were recruited from Canada, Greece, Italy, Poland, and Israel. Assessments generally were performed in the individuals' homes.
Participants Forty-three percent of 1199 volunteers had largely white European backgrounds. The remaining individuals were recruited for family and case-control studies with focus on Ashkenazi Jews. All individuals had a consensus diagnosis of schizophrenia (including schizoaffective disorder) using DSM-III or DSM-IV criteria.
Main Outcome Measures The 73 indicators were subjected to principal components factor analysis, and factor scores representing 9 dimensions were analyzed for familiality.
Results The 9 factors include the often-reported delusions, hallucinations, disorganization, negative, and affective factors; novel factors included child/adolescent sociability, scholastic performance, disability/impairment, and prodromal factors. All 9 factors demonstrated significant familiality (measured by a heritability statistic), with the highest scores for disability/impairment (0.61), disorganization (0.60), and scholastic performance (0.51).
Conclusions The factor scores show varying degrees of familiality and may prove useful as quantitative traits and covariates in linkage and association studies.
INTRODUCTION
Schizophrenia (SZ) is a disabling complex disease with a prevalence of about 1%,1 typically arising in late adolescence or early adulthood. Symptoms, which include delusions, paranoia, anhedonia, hallucinations, lack of motivation, and cognitive and affective disturbances, can vary substantially between patients and over time. The etiology of SZ remains unknown; however, twin, adoption, and family studies suggest genetic involvement with heritability estimated to be as high as 70% to 85%.2-3 It has been suggested that 3 or 4 loci with likely epistatic interactions might be involved in SZ susceptibility.4 Linkage studies have implicated more than a dozen chromosomal regions5; however, various meta-analytic methods have not substantially reduced this number.6-7 Genomewide significance has been demonstrated only for regions on chromosomes 13q8 and 1q.9 Association studies have followed linkage studies or investigated functional candidate genes,10-11 with some promising results; however, findings have not been conclusively replicated.12
It is reasonable to posit that the complexity of the SZ phenotype reflects, at least in part, the complexity of the underlying genetics. Researchers have increasingly pursued methods for reliably measuring simplified attributes of SZ in the hope that genetic associations with such intermediate phenotypes will be more easily detected.13 The application of data reduction techniques such as factor analysis to clinical signs and symptoms has been used to delineate several dimensions of SZ14-25 such as the positive (delusions and hallucinations), disorganization (in thought and behavior), and negative (deficit symptoms such as apathy and avolition) dimensions.13 However, differences in the symptoms ascertained, the scope of data collected (eg, cross-sectional and lifetime), data sources (eg, informant, individual, and medical record), recruitment sources, sample composition, and measurement error all contribute to variations in factor structure results.
The present study presents a principal components factor analysis (PCFA) of 73 indicators that include not only the frequently analyzed positive, disorganization, negative, and affective features of SZ but also additional elements such as social and occupational deterioration as well as earlier signs of dysfunction such as troubled child/adolescent sociability and scholastic performance. The objectives of the study were to determine the factors that best describe the interrelationships among these indicators in a sample of 1199 individuals and to examine the familiality of these factor scores for potential use in genetic studies.
METHODS
PARTICIPANTS
Individuals participated in institutional review board–approved studies within the Epidemiology-Genetics Program in Psychiatry, The Johns Hopkins University School of Medicine, Baltimore, Maryland. For simplification, they can be grouped into 2 categories: 513 outbred (OB) individuals (94% European Caucasian backgrounds and 6% African American) and 686 Jews of European ancestry including 685 Ashkenazi Jews (AJ) (89% full AJ and 11% partly AJ) and 1 Sephardic Jew. We asked about the heritage and country of origin of all 4 grandparents to establish the full AJ classification. Recruitment criteria have been previously described.8, 26 Most OB individuals were examined between April 18, 1988, and December 14, 1996, and the Jewish participants between July 25, 1996, and May 24, 2006. Most OB individuals were ascertained for multiplex family (ie, more than 1 affected family member) studies: 77% have an affected relative in the data set vs 13% of AJs (most of the latter were ascertained for case-control studies).
We began the OB studies using a modified Diagnostic Interview Schedule27-30; we included a broader range of psychosis items, used experienced clinicians (M.H.T. and J.R.L. among others) (ie, with a master's, PhD, or MD degree) rather than lay interviewers, and encouraged interviewers to break from the probe flow when necessary to clarify information. Interviews were audiotaped for quality control. Approximately halfway into the OB assessments, we switched from the modified Diagnostic Interview Schedule (49% of OB individuals) to the Diagnostic Interview for Genetic Studies (DIGS)31 and from a DSM-III-R32 consensus diagnostic checklist (46% of OB individuals) to a DSM-IV33 consensus checklist. All AJs were interviewed using the DIGS and were rated using the DSM-IV checklist. A total of 47 interviewers participated during the 18-year period. To maintain standardization, the interviewers were supervised by a lead psychologist (one from 1988 to 1995 and one of us [M.H.T.] from 1995 onward) who conducted training and follow-up monitoring (review of audiotaped interviews).
The consensus diagnostic procedure was identical for OB and AJ individuals, with at least 2 diagnosticians reviewing data from the interview, medical records, and informants to form consensus on diagnoses and key criteria. A total of 31 diagnosticians participated during the 18 years; one of us (G.N.) oversaw diagnostic committee meetings throughout this period to maintain standardization.
In total, 1199 individuals from 921 families met criteria for inclusion in the studies and gave informed consent to participate. There were 428 women (36%) and 771 men (64%) with a consensus research diagnosis of SZ (n = 1018 [85%]) or schizoaffective disorder (n = 181 [15%]). Their mean (SD) age at assessment was 40.7 (11.9) years, and at onset of psychosis was 21.1 (6.3) years.
INDICATOR SELECTION
Since initiation of the Epidemiology-Genetics Program, we have made a fundamental effort to measure a broad range of phenomena representing the clinical heterogeneity of SZ with the goal of eventually sorting out which aspects are related to genetic variation. The supposition behind this effort is that SZ is likely several related disorders with varying and sometimes overlapping genetic underpinnings, some of which affect clinical and course features. While we respect the operational rigor that current diagnostic systems supply, we recognize that no symptoms are pathognomonic for SZ. We, therefore, embedded both the modified Diagnostic Interview Schedule and the DIGS with a common set of items related not only to the major criteria of SZ but also to antecedent and concurrent signs. Table 1 lists the 73 lifetime indicators chosen for the PCFA, all coded 1 (present) or 0 (absent). The indicators are largely related to DSM-IV diagnostic criteria (Table 1). In contrast to most factor analytic studies that focus only on SZ criterion A items (some with attention to mania and depression), we included indicators representing the broader domains of psychopathology as articulated, for example, by Carpenter35: items related to SZ criteria B and C, and associated signs/symptoms and course of illness variables, as well as affective spectrum indicators,36-37 all of which have been studied in efforts to diagnose or subtype SZ. Table 1 gives indicators from our interviews vs the consensus diagnostic checklist. Also footnoted are items relating to criteria B and C, which were adapted from the Premorbid Adjustment Scale34 and embedded in our interviews; we rated these child and adolescent items regardless of age at onset of psychosis. We considered including age at onset of psychosis in the factor analysis but chose to withhold it as a potentially powerful characteristic for genetic dissection on its own.
|
|
|
|
Table 1. Seventy-three Indicators Included in the Principal Components Factor Analysis: Prevalence, Missing Rates, and Diagnostic Relevancea
|
|
|
PCFA AND MISSING DATA IMPUTATION
Commercially available software (SAS version 9.1; SAS Institute, Inc, Cary, North Carolina) was used for the analyses. Indicator missing data rates varied from approximately 2% to 44% (mean, 16%; median, 14%; Table 1). A small portion of the missing data are owing to missing interviews (approximately 5% of individuals did not complete an interview because of refusal, incapacitation, or location [we have only summaries of the assessments conducted in Italy]). Four interview items (among the top 12 indicators for missing data) were not added until adoption of the DIGS (Table 1). However, the primary reason for missing data is that the interviewer or diagnostician judged information insufficient to code a given indicator. For example, 7 of the 9 indicators with 30% or more missing data dealt with prodromal symptoms (in the year preceding psychosis onset) and suddenness of onset; these events occurred on average 20 years before the interview and illustrate the care with which raters made their codings. We used multiple imputation (SAS Proc MI; SAS Institute, Inc) using the Markov chain Monte Carlo method to replace missing data with pseudorandom draws from the simulated multidimensional distributions. Three to 10 imputations are usually sufficient38; we generated 5 imputation data sets, which were analyzed individually using PCFA (SAS Proc Factor; SAS Institute, Inc) with varimax rotation. Although our primary goal was generation of orthogonal dimensional scores for genetic analyses, we also conducted an oblique rotation using imputation data set 1 (obvarimax method39) to examine intercorrelations among factor scores not constrained to be orthogonal.
Underextraction or overextraction of factors is considered a critical problem in factor analysis. Often-used methods for deciding on the number of factors include the Kaiser criterion (eigenvalue >1) and examination of the scree plot of descending eigenvalues to determine a point at which the eigenvalues level off40; however, the former method tends to result in specification of too many factors and the latter method can be unreliable.41-42 We, therefore, used 2 statistically based methods for factor number determination: parallel analysis and the Velicer Minimum Average Partial correlation method.41-44 Ten thousand parallel analyses were run with random multivariate normal data. The Velicer Minimum Average Partial test was conducted using correlation matrices from each of the 5 imputation data sets. Simulation studies have shown that both of these methods for factor number determination are accurate.44
Factor scores were calculated using the score option (SAS Institute, Inc) within the factor procedure, which generates scoring coefficients for each indicator-factor combination based on the factor structure. Raw indicator values for a given individual are standardized, multiplied by the appropriate scoring coefficient, and summed to produce the factor scores. The 5 sets of 9 factor scores (1 for each imputation data set) were averaged into 1 set of 9 for familiality analyses. Pearson intercorrelations with age at onset of psychosis were also examined.
FAMILIALITY ANALYSES
We calculated heritability estimates for the factor scores using the ASSOC program from the Statistical Analysis for Genetic Epidemiology (SAGE) package (version 5.4.1).45 For a given sample made up of pedigrees of related individuals, some of whom have been measured on a given quantitative trait, ASSOC partitions the variance of the trait into components that reflect (depending on model specification) additive polygenic effects vs sibship effects, nuclear family effects, marital effects, and random individual environment effects. Heritability is calculated as the ratio of polygenic variance to total variance. Note that, while the ASSOC program produces a heritability statistic for a given trait, our specialized sample ascertainment does not permit this to be interpreted as an estimate of heritability in a general population. We interpret heritability simply as an index of familiality within this sample. We calculated heritability with and without an adjustment (adding a covariate coded 1 for individuals with SZ with affected relatives in the analysis vs 0 for singletons) to illustrate the attenuation of some of the observed heritability values if one adjusts for a degree of within-family sameness produced by ascertaining mainly multiplex families.
Although the factor scores have an assumed underlying normal distribution, not all of the generated distributions met this expectation. We tested several transformation methods to normalize the distributions, as preferred for both heritability analyses and quantitative trait locus linkage analyses46: the George-Elston modulus power transformation47 (implemented in SAGE), the Box-Cox power transformation,48 and the natural log power transformation (the latter 2 implemented with STATA Release 8.0; Stata Corp, College Station, Texas). The final transformations chosen are given in Table 3 ("Results" section); the transformed score distributions were also standardized to have a mean of zero and variance of unity. The transformed factor scores in extended pedigrees were analyzed for their polygenic and random variance components. Familiality analysis included the 1199 individuals with SZ plus 553 additional individuals (without factor scores) from these families needed to delineate the relationships among the affected members (eg, unaffected parents added to connect 2 affected siblings). Of the 1199 individuals with SZ, 714 were singletons. The SAGE ASSOC program treats these individuals as coming from pedigrees of size 1 each and uses these observations in producing the variance estimates underlying the heritability calculations.
RESULTS
FACTOR ANALYSIS
The Velicer Minimum Average Partial Correlation Test suggested 8 components in each of the 5 imputation data sets. The parallel analysis, however, indicated that 15 factors could be extracted (Figure). We examined solutions sequentially from 8 to 15 factors using each of the 5 imputation data sets, and solutions for 8 or 9 factors were consistent across the 5 imputation data sets, whereas expanding beyond this introduced more substantive variability in the later factors. The difference between the 8- and 9-factor solutions was that several types of hallucinations separated from most delusion symptoms as the ninth factor rather than loading with delusions on a single factor. We chose to keep the 9-factor model. While previous studies have achieved both types of solutions (a single positive symptom factor17, 22, 49-50 vs separate delusion vs hallucination factors51-52), the hallucination items had slightly higher factor loadings when coalescing on the ninth factor than when mixing with delusions in the 8-factor model. The 9 components accounted for 35.4% of the total variance in imputation data set 1 (Figure).
|
|
|
|
Figure. Comparison of eigenvalues from principal components factor analysis of imputation 1 data (1199 individuals) vs 10 000 parallel analyses of permuted random data. Notes: Permuted random data eigenvalues represent the 95th percentile value for each component, over the 10 000 parallel analyses (ie, analyses of 10 000 permuted data sets). Although not shown, the eigenvalues for imputation 1 data remain at or above 1.0 through component 23; that is, the Kaiser rule would result in extraction of 23 components. Attempting to judge the number of factors to extract based on the scree plot also presents difficulties (different judges may disagree on the cutoff point). With use of parallel analytic techniques, the permuted random data values yield a 15-factor solution. This is also true when using permutations of the imputation 1 data set for the 10 000 parallel analyses (eigenvalues are almost identical to the permuted random data results shown here).
|
|
|
Table 2 gives primary factor loadings with absolute values greater than or equal to 0.30 from the varimax rotated 9-factor solution using imputation data set 1; similar loadings were obtained for the other 4 data sets. Although the 0.30 cutoff is lower than in some studies, it permits display of indicator relationships that are milder yet significant (eg, loadings on the hallucination factor). Negative loadings indicate an inverse relationship; for example, individuals with more disability/impairment tend to have a nonremitting course. The full set of loadings is given in eTable 1). The schneiderian factor is so named because it is dominated by indicators historically known as first-rank symptoms (eg, thought insertion and withdrawal, thought echo and broadcasting, delusions of influence, and primary delusional perception), which Schneider considered to be core features of SZ.53
|
|
|
|
Table 2. Factor Loadings Greater Than or Equal to the Absolute Value of 0.30 for the 9-Factor Principal Components Factor Analysis (1199 Individuals, Varimax Rotation)a
|
|
|
Age at onset showed weak correlations with several factors including hallucinations (r = –0.12; P < .002), child/adolescent sociability (r = 0.09; P < .006), scholastic performance (r = 0.20; P < .001), disability/impairment (r = –0.10; P < .003), and the prodromal factor (r = –0.09; P < .003). Oblique factor loadings are given in eTable 2. Many of the oblique factors were significantly intercorrelated; however, most associations were weak (eg, r < 0.15; eTable 3).
FAMILIALITY OF FACTORS
The heritabilities of the 9 varimax factors are given in Table 3, calculated for 207 families with multiple affected members and 714 singletons, with and without adjustment for ascertainment bias. The method of factor score transformation along with the relevant transformation parameters for each factor ( 1 for the George-Elston modulus power transformation and k for the natural log power transformation) are given in Table 3. All factors showed statistically significant heritabilities whether adjusted or not. Unadjusted values varied from 0.27 for child/adolescent sociability to 0.61 for disability/impairment. Table 4 gives the predominance of affected sibling pairs existing in the multiplex families included in the heritability analyses (affected-pair correlations were produced using the SAGE FCOR program).
|
|
|
|
Table 3. Heritability Estimates for 9 Sets of Factor Scores (1199 Individuals)
|
|
|
|
|
|
|
Table 4. Affected Pairs Contributing to Heritability Calculations (Correlations for Disorganization Factor)
|
|
|
COMMENT
At least 5 of the 9 PCFA factors (hallucinations, disorganization, negative, schneiderian, and affective) cover previously often-described dimensions of psychotic disorders.14, 16-17,20, 51, 54-59 In these studies, dimensions have sometimes been broken down (eg, affective is separated into mania and depression in studies that include a greater variety of affective indicators) or combined (eg, delusions and hallucinations often join as positive symptoms). This variation is not unusual. Jablensky points out that "factor-analytical studies suggesting established dimensions or syndromes of schizophrenia should be viewed with caution, considering the diversity of clinical populations and the limitations of the instruments used to generate the input data."13(p821) Four of the dimensions we studied are somewhat novel, not in their pertinence to aspects of SZ but in their description through factor analysis (these include the childhood/adolescent sociability, scholastic performance, disability/impairment, and prodromal factors). However, aspects of asociality have been factor analyzed in the adult context (eg, as disordered relating52, 55, 60-61).
The disorganization and negative factor heritabilities are consistent with studies that show familial aggregation for similar or related dimensions57, 62-66 and studies that link these dimensions to increased risk of psychosis or SZ in relatives.23, 25, 67 Familiality of disorganization seems to be most consistent across studies. A recent meta-analysis of sib-pair studies supports the familiality of disorganization but shows more equivocal results for reality distortion (delusions or hallucinations) and the psychomotor poverty dimension (related to our negative dimension).68 Similarly, another recent sib-pair study by Vassos et al69 supported the familiality of a positive/disorganized factor (as well as positive/delusional and dysphoric factors) but not a negative factor.
Substantial literature exists on the deficit syndrome of SZ,24, 70 defined by enduring negative symptoms that are not secondary to other conditions such as depression, anxiety, or drug effects.23 The indicators with major loadings on the negative factor (Table 1) encompass the deficit syndrome domain; however, our assessment does not establish the duration criterion of the deficit syndrome. Still, the mild but significant inverse relationship between the affective and negative factors when obliquely rotated (r = –0.15, eTable 3) reinforces the supposition that the negative symptoms in this sample are not secondary to depression. The positive loading for poor insight (0.30) on the negative factor (Table 2) is consistent with research that associates this illness feature with the deficit syndrome.71 Likewise, the positive loadings for self-neglect (0.30) and severe psychotic disorder (0.39) and negative loading for remitting course (–0.22, eTable 3) are all consistent with the finding of poorer outcome for individuals with deficit syndrome.23
The schneiderian factor heritability is consistent with several other studies that have demonstrated significant sib-pair correlations for this nuclear syndrome.72-73 While the heritability estimate of Cardno et al73 (0.71) is quite a bit higher than in the present study, it came out of a more ideal sample of monozygotic and dizygotic twins. Our schneiderian factor contains some indicators that are not first rank and this, along with sample characteristics and randomness introduced by multiple imputation, may account for the difference.
We are unaware of previous studies in probands and relatives with SZ that demonstrate familial aggregation of child/adolescent sociability, scholastic performance, disability/impairment, or prodromal factors. However, Vassos et al69 included Premorbid Adjustment Scale and Global Assessment of Functioning Scale scores (scale scores, not factor scores) in their sib-pair study and found evidence of familiality for both of these (our child/adolescent sociability and scholastic performance factors draw heavily on the Premorbid Adjustment Scale items, and our disability/impairment factor likely reflects some aspects of the variation captured by the Global Assessment of Functioning Scale).
The lowest heritabilities were found for the child/adolescent sociability factor (0.27) and the prodromal factor (0.36). The prodromal indicators are affected most by missing data. They involve subclinical behaviors and internal experiences in the year immediately before the illness was diagnosed (on average, almost 20 years before the interview). Likewise, individual recall of the childhood/adolescent sociability indicators might be more affected than for other signs, given the greater passage of time. It is also possible that prodromal and asociality symptoms characterize SZ variants more commonly produced by environmental exposures or de novo genetic events74-77 and that this accounts for the lower heritabilities. Nevertheless, the familial aggregation for these dimensions is statistically significant, which suggests that genetic analyses may still be warranted. By way of indirect comparison with the familiality estimate for child/adolescent sociability, a healthy-twin study of the extraversion factor (from the NEO-PI-R personality questionnaire) estimated heritability to be 0.53.78
Premorbid maladjustment has been associated with earlier age at onset and more likelihood of negative symptoms.79 We observed a mild association of the child/adolescent sociability and scholastic performance factors with age at onset; however, even with oblique rotation, we did not find an association of the negative dimension with these factors (eTable 3).
The scholastic factor in part reflects cognitive functioning, a complex domain that has been deeply explored in SZ; specific cognitive phenotypes80 and endophenotypes81-83 are being pursued as vehicles for subtyping SZ. Scholastic performance has been studied in healthy populations and is strongly related to genetic factors; for example, a recent twin study suggested a heritability for academic achievement of 0.72 to 0.76, substantially correlated with verbal IQ.84 The present study cannot answer the question as to whether the scholastic performance factor variation is also related to SZ susceptibility per se. However, studies implicate cognitive dysfunction as a precursor to SZ.85-86 In addition, the endophenotypic nature of various cognitive deficits for SZ has been established; thus, to the extent that the scholastic performance factor carries some of this cognitive variation, it may be reflecting variation related to SZ susceptibility. The present study also suggests that the scholastic performance variation is not simply a proxy for other illness aspects, as seen in the relatively low correlations of the scholastic performance factor with other factors when obliquely rotated (eTable 3).
Although the scholastic performance factor is an admittedly blunt metric for cognitive problems and is likely affected by contaminating influences (eg, socioeconomic status), it fits into a line of research by MacCabe et al,87 who tested educational markers as a means for subtyping SZ. MacCabe et al87 compared 2 groups of inpatients with SZ on OPCRIT88 and other case note–rated symptoms, as well as on principal component factor scores. Their 46 university-educated patients vs 48 non–university-educated patients were matched by sex and age at diagnosis. University-educated individuals had significantly lower scores on a principal component made up of SZ symptoms and significantly higher scores on a reactive depression component, which suggests that they might represent a subtype. They were also more likely to have experienced a psychosocial stressor before onset and had a less chronic course of illness. A more recent study by MacCabe et al89 in a Swedish birth cohort showed that the risk of adult-onset SZ and other psychosis is significantly related to poorer scholastic achievement at age 15 to 16 years, ruling out confounding by socioeconomic status, parental educational achievement level, migrant status, low birthweight, and hypoxia.
A key strength of the present study is the inclusion of indicators of social adaptation, school/occupational dysfunction, and prodromal symptoms, rounding out the more typically analyzed items characterizing psychosis per se. While studies vary in the types of assessments conducted, there can be opportunities for replication when similar domains are measured using well-operationalized tools even if these are not identical to those in the present study (eg, the DIGS and Premorbid Adjustment Scale). Use of the relatively large sample of individuals tends to produce more stable factor analytic solutions, increasing the likelihood of replication. Using statistical methods for factor number determination is also a strength, although even the best 2 methods showed divergence. The relatively large pool of indicators (73) was well divided among the various factors so that 8 of 9 factors have at least 4 to 5 substantial loadings (greater than or equal to the absolute value of 0.40). The hallucination factor is weaker in this regard. The affective factor is somewhat limited in the number of indicators loading on it. Inclusion of a greater number and variety of affective symptoms would likely result in generation of separate mania and depression factors. Another limitation is the ascertainment of some of the indicators (especially child and adolescent period items) primarily from individual reports via the diagnostic interview. It is possible that issues of recall and reporting bias can arise here more than with the SZ symptom indicators, which benefit from the addition of medical record and informant or clinician information used for consensus diagnosis. However, countering this potential weakness was our reliance on professional clinical examiners who could make in-depth probes and who held judgments in abeyance when the interview information proved weak. Despite the introduction of imputed values for missing data, we observed substantively sensible factors that show significant evidence of familial aggregation. The percentage of variance accounted for (35.4%) is somewhat lower than in many studies but likely is owing to the greater diversity of indicators here and the use of multiple imputation (introducing randomness).
CONCLUSIONS
A lingering question is whether alternative phenotypes with modest-to-moderate heritabilities (such as the present collection) can perform usefully in genetic studies of a disorder with a high heritability (eg, 70%-85% for SZ). In favor of this possibility, it must be emphasized that, although SZ is associated with relatively high heritability, this does not imply that strong or even moderate genetic effects lead to susceptibility. A common hypothesis is that SZ susceptibility arises from multiple genes of modest effect. If these loci have different phenotypic expressions (related to some of the dimensions explored in this study), the power to detect genetic associations will be greater for the quantitative measures vs discrete phenotypes. We are exploring the use of the factor scores as phenotypes in quantitative trait locus linkage and association studies. Other potential uses are as covariates or stratification variables. The factor scores may also prove useful in the eventual clinical characterization of individuals known to share a specific genetic variant that increases their susceptibility to SZ.
AUTHOR INFORMATION
Correspondence: Ann E. Pulver, ScD, Department of Psychiatry, The Johns Hopkins University School of Medicine, 1820 Lancaster St, Ste 300, Baltimore, MD 21231 (aepulver{at}jhmi.edu).
Submitted for Publication: August 11, 2008; final revision received October 8, 2008; accepted November 23, 2008.
Financial Disclosure: None reported.
Funding/Support: This study was supported by grants ROl MH57314 and RO1 MH068406 from the National Institute of Mental Health (Dr Pulver). The SAGE software package is supported by US Public Health Service Resource grant RR03655 from the National Center for Research Resources.
Additional Contributions: Paul Costa Jr, PhD, provided valuable advice during the planning phase of the factor analysis. We thank the individuals and their families who participated in this study and continue to support this research program.
Author Affiliations: Department of Psychiatry (Mr McGrath, Drs Avramopoulos, Nestadt, Thornquist, Luke, and Pulver, and Mss Lasseter and Wolyniec), McKusick-Nathans Institute of Genetic Medicine (Drs Avramopoulos, Chen, and Valle), and Bloomberg School of Public Health (Drs Fallin, Liang, and Pulver), The Johns Hopkins University, Baltimore, Maryland.
REFERENCES
1. Gottesman I, Shields J, Hanson D. Schizophrenia: The Epigenetic Puzzle. New York, NY: Cambridge University Press; 1982.
2. Tsuang MT, Gilbertson MW, Faraone SV. The genetics of schizophrenia: current knowledge and future directions. Schizophr Res. 1991;4(2):157-171.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
3. McGue M, Gottesman II. Genetic linkage in schizophrenia: perspectives from genetic epidemiology. Schizophr Bull. 1989;15(3):453-464.
FREE FULL TEXT
4. Risch N. Linkage strategies for genetically complex traits, I: multilocus models [see comments]. Am J Hum Genet. 1990;46(2):222-228.
WEB OF SCIENCE
| PUBMED
5. Owen MJ, Craddock N, O'Donovan MC. Schizophrenia: genes at last? Trends Genet. 2005;21(9):518-525.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
6. Badner JA, Gershon ES. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry. 2002;7(4):405-411.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
7. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, Brzustowicz LM, Kaufmann CA, Garver DL, Gurling HM, Lindholm E, Coon H, Moises HW, Byerley W, Shaw SH, Mesen A, Sherrington R, ONeill FA, Walsh D, Kendler KS, Ekelund J, Paunio T, Lönnqvist J, Peltonen L, ODonovan MC, Owen MJ, Wildenauer DB, Maier W, Nestadt G, Blouin JL, Antonarakis SE, Mowry BJ, Silverman JM, Crowe RR, Cloninger CR, Tsuang MT, Malaspina D, Harkavy-Friedman JM, Svrakic DM, Bassett AS, Holcomb J, Kalsi G, McQuillin A, Brynjolfson J, Sigmundsson T, Petursson H, Jazin E, Zoëga T, Helgason T. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet. 2003;73(1):34-48.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
8. Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, Thornquist M, Ullrich G, McGrath J, Kasch L, Lamacz M, Thomas MG, Gehrig C, Radhakrishna U, Snyder SE, Balk KG, Neufeld K, Swartz KL, DeMarchi N, Papadimitriou GN, Dikeos DG, Stefanis CN, Chakravarti A, Childs B, Housman DE, Kazazian HH, Antonarakis S, Pulver AE. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet. 1998;20(1):70-73.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
9. Brzustowicz LM, Hodgkinson KA, Chow EW, Honer WG, Bassett AS. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science. 2000;288(5466):678-682.
FREE FULL TEXT
10. Lang UE, Puls I, Muller DJ, Strutz-Seebohm N, Gallinat J. Molecular mechanisms of schizophrenia. Cell Physiol Biochem. 2007;20(6):687-702.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
11. McGuffin P. Gene polymorphisms and behavior. Pediatr Blood Cancer. 2007;48(7):736-737.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
12. Riley B, Kendler KS. Molecular genetic studies of schizophrenia. Eur J Hum Genet. 2006;14(6):669-680.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
13. Jablensky A. Subtyping schizophrenia: implications for genetic research. Mol Psychiatry. 2006;11(9):815-836.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
14. Strauss JS, Carpenter WT Jr, Bartko JJ. The diagnosis and understanding of schizophrenia, part III: speculations on the processes that underlie schizophrenic symptoms and signs. Schizophr Bull. 1974;(11):61-69.
PUBMED
15. Crow TJ. Molecular pathology of schizophrenia: more than one disease process? Br Med J. 1980;280(6207):66-68.
FREE FULL TEXT
16. Crow TJ. Positive and negative schizophrenia symptoms and the role of dopamine. Br J Psychiatry. 1981;139:251-254.
FREE FULL TEXT
17. Andreasen NC, Olsen SA. Negative v. positive schizophrenia: definition and validation. Arch Gen Psychiatry. 1982;39(7):789-794.
FREE FULL TEXT
18. Kay SR, Opler LA, Fiszbein A. Significance of positive and negative syndromes in chronic schizophrenia. Br J Psychiatry. 1986;149:439-448.
FREE FULL TEXT
19. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276.
FREE FULL TEXT
20. Bell MD, Lysaker PH, Beam-Goulet JL, Milstein RM, Lindenmayer JP. Five-component model of schizophrenia: assessing the factorial invariance of the positive and negative syndrome scale. Psychiatry Res. 1994;52(3):295-303.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
21. Lindenmayer JP, Bernstein-Hyman R, Grochowski S. Five-factor model of schizophrenia: initial validation. J Nerv Ment Dis. 1994;182(11):631-638.
WEB OF SCIENCE
| PUBMED
22. Buchanan RW, Carpenter WT. Domains of psychopathology: an approach to the reduction of heterogeneity in schizophrenia. J Nerv Ment Dis. 1994;182(4):193-204.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
23. Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT Jr. A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry. 2001;58(2):165-171.
FREE FULL TEXT
24. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT Jr. The Schedule for the Deficit Syndrome: an instrument for research in schizophrenia. Psychiatry Res. 1989;30(2):119-123.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
25. McGrath JA, Nestadt G, Liang K-Y, Lasseter VK, Wolyniec PS, Fallin MD, Thornquist MH, Luke JR, Pulver AE. Five latent factors underlying schizophrenia: analysis and relationship to illnesses in relatives. Schizophr Bull. 2004;30(4):855-873.
FREE FULL TEXT
26. Fallin MD, Lasseter VK, Wolyniec PS, McGrath JA, Nestadt G, Valle D, Liang KY, Pulver AE. Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22. Am J Hum Genet. 2003;73(3):601-611.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
27. Pulver AE, Carpenter WT Jr. Lifetime psychotic symptoms assessed with the DIS. Schizophr Bull. 1983;9(3):377-382.
FREE FULL TEXT
28. Pulver AE, Wolyniec PS, Wagner MG, Moorman CC, McGrath JA. An epidemiologic investigation of alcohol-dependent schizophrenics. Acta Psychiatr Scand. 1989;79(6):603-612.
WEB OF SCIENCE
| PUBMED
29. Pulver AE, Bale SJ. Availability of schizophrenic patients and their families for genetic linkage studies: findings from the Maryland epidemiology sample. Genet Epidemiol. 1989;6(6):671-680.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
30. Pulver AE, Karayiorgou M, Wolyniec PS, Lasseter VK, Kasch L, Nestadt G, Antonarakis S, Housman D, Kazazian HH, Meyers D, Ott J, Lamacz M, Liang KY, Hanfelt J, Ullrich G, DeMarchi N, Ramu E, McHugh PR, Adler L, Thomas M, Carpenter WT, Manschreck T, Gordon CT, Kiimberland M, Babb R, Puck J, Childs B. Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12-q13.1: part 1. Am J Med Genet. 1994;54(1):36-43.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
31. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T, NIMH Genetics Initiative. Diagnostic interview for genetic studies: rationale, unique features, and training. Arch Gen Psychiatry. 1994;51(11):849-859, discussion 863-864.
FREE FULL TEXT
32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, revised. Washington, DC: American Psychiatric Association; 1987.33. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.34. Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull. 1982;8(3):470-484.
FREE FULL TEXT
35. Carpenter WT Jr. Clinical constructs and therapeutic discovery. Schizophr Res. 2004;72(1):69-73.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
36. Hudson JI, Mangweth B, Pope HG Jr, De Col C, Hausmann A, Gutweniger S, Laird NM, Biebl W, Tsuang MT. Family study of affective spectrum disorder. Arch Gen Psychiatry. 2003;60(2):170-177.
FREE FULL TEXT
37. Nechmad A, Ratzoni G, Poyurovsky M, Meged S, Avidan G, Fuchs C, Bloch Y, Weizman R. Obsessive-compulsive disorder in adolescent schizophrenia patients. Am J Psychiatry. 2003;160(5):1002-1004.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
38. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res. 1999;8(1):3-15.
FREE FULL TEXT
39. SAS. SAS/STAT 9.1 User's Guide. Cary, NC: SAS Institute Inc; 2004.40. Kim J, Mueller C. Factor Analysis: Statistical Methods and Practical Issues. Beverly Hills, CA: SAGE Publications; 1978.41. Hayton J, Allen D, Scarpello V. Factor retention decisions in exploratory factor analysis: a tutorial on parallel analysis. Organ Res Methods. 2004;7(2):191-205. doi:10.1177/1094428104263675.
FULL TEXT
|
WEB OF SCIENCE
42. O'Connor BP. SPSS and SAS programs for determining the number of components using parallel analysis and Velicer's MAP test. Behav Res Methods Instrum Comput. 2000;32(3):396-402.
WEB OF SCIENCE
| PUBMED
43. Franklin S, Gibson D, Robertson P, Pohlmann J, Fralish J. Parallel analysis: a method for determining significant principal components. J Vegetation Sci. 1995;6(1):99-106. doi:10.2307/3236261.
FULL TEXT
44. Velicer W, Eaton C, Fava J. Construct explication through factor or component analysis: a review and evaluation of alternative procedures for determining the number of factors or components. In: Goffin R, Helmes E, eds. Problems and Solutions in Human Assessment: Honoring Douglas N. Jackson at Seventy. Norwell, NJ: Kluwer Academic Publishers; 2000:41-71.45. SAGE. Statistical Analysis for Genetic Epidemiology (SAGE) Version 5.4.1 User Reference Manual. Cleveland, OH: Case Western University; 2007.46. Sham PC, Purcell S, Cherny SS, Abecasis GR. Powerful regression-based quantitative-trait linkage analysis of general pedigrees. Am J Hum Genet. 2002;71(2):238-253.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
47. George VT, Elston RC. Generalized modulus power transformations. Commun Statistics Theory Methods. 1988;17(9):2933-2952. doi:10.1080/0361092880882978.
FULL TEXT
48. Box GEP, Cox DR. An analysis of transformations. J R Stat Soc B. 1964;26:211-252.
49. Klimidis S, Stuart GW, Minas IH, Copolov DL, Singh BS. Positive and negative symptoms in the psychoses: re-analysis of published SAPS and SANS global ratings. Schizophr Res. 1993;9(1):11-18.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
50. Brekke JS, DeBonis JA, Graham JW. A latent structure analysis of the positive and negative symptoms in schizophrenia. Compr Psychiatry. 1994;35(4):252-259.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
51. Cardno AG, Jones LA, Murphy KC, Asherson P, Scott LC, Williams J, Owen MJ, McGuffin P. Factor analysis of schizophrenic symptoms using the OPCRIT checklist. Schizophr Res. 1996;22(3):233-239.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
52. Toomey R, Kremen WS, Simpson JC, Samson JA, Seidman LJ, Lyons MJ, Faraone SV, Tsuang MT. Revisiting the factor structure for positive and negative symptoms: evidence from a large heterogeneous group of psychiatric patients. Am J Psychiatry. 1997;154(3):371-377.
WEB OF SCIENCE
| PUBMED
53. Schneider K. Primary and secondary symptoms in schizophrenia. In: Hirsch SR, Shepherd M, eds. Themes and Variations in European Psychiatry: An Anthology. Charlottesville, VA: University Press of Virginia; 1974:40-44.54. Peralta V, Cuesta MJ, de Leon J. An empirical analysis of latent structures underlying schizophrenic symptoms: a four-syndrome model. Biol Psychiatry. 1994;36(11):726-736.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
55. Lenzenweger MF, Dworkin RH. The dimensions of schizophrenia phenomenology: not one or two, at least three, perhaps four. Br J Psychiatry. 1996;168(4):432-440.
FREE FULL TEXT
56. White L, Harvey PD, Opler L, Lindenmayer JP, The PANSS Study Group. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: a multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. Psychopathology. 1997;30(5):263-274.
WEB OF SCIENCE
| PUBMED
57. Cardno AG, Jones LA, Murphy KC, Sanders RD, Asherson P, Owen MJ, McGuffin P. Dimensions of psychosis in affected sibling pairs. Schizophr Bull. 1999;25(4):841-850.
FREE FULL TEXT
58. Van Os J, Gilvarry C, Bale R, Van Horn E, Tattan T, White I, Murray R, UK700 Group. A comparison of the utility of dimensional and categorical representations of psychosis. Psychol Med. 1999;29(3):595-606.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
59. Arajärvi R, Haukka J, Varilo T, Suokas J, Juvonen H, Suvisaari J, Muhonen M, Suominen K, Tuulio-Henriksson A, Schreck M, Hovatta I, Partonen T, Lönnqvist J. Clinical phenotype of schizophrenia in a Finnish isolate. Schizophr Res. 2004;67(2-3):195-205.
FULL TEXT
| PUBMED
60. Emsley RA, Niehaus DJ, Mbanga NI, Oosthuizen PP, Stein DJ, Maritz JS, Pimstone SN, Hayden MR, Laurent C, Deleuze JF, Mallet J. The factor structure for positive and negative symptoms in South African Xhosa patients with schizophrenia. Schizophr Res. 2001;47(2-3):149-157.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
61. Minas IH, Klimidis S, Stuart GW, Copolov DL, Singh BS. Positive and negative symptoms in the psychoses: principal components analysis of items from the Scale for the Assessment of Positive Symptoms and the Scale for the Assessment of Negative Symptoms. Compr Psychiatry. 1994;35(2):135-144.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
62. Burke JG, Murphy BM, Bray JC, Walsh D, Kendler KS. Clinical similarities in siblings with schizophrenia. Am J Med Genet. 1996;67(3):239-243.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
63. Kendler KS, Karkowski-Shuman L, O'Neill FA, Straub RE, MacLean CJ, Walsh D. Resemblance of psychotic symptoms and syndromes in affected sibling pairs from the Irish Study of High-Density Schizophrenia Families: evidence for possible etiologic heterogeneity. Am J Psychiatry. 1997;154(2):191-198.
WEB OF SCIENCE
| PUBMED
64. Loftus J, DeLisi LE, Crow TJ. Familial associations of subsyndromes of psychosis in affected sibling pairs with schizophrenia and schizoaffective disorder. Psychiatry Res. 1998;80(2):101-111.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
65. Ross DE, Kirkpatrick B, Karkowski LM, Straub RE, MacLean CJ, O'Neill FA, Compton AD, Murphy B, Walsh D, Kendler KS. Sibling correlation of deficit syndrome in the Irish Study of High-Density Schizophrenia Families. Am J Psychiatry. 2000;157(7):1071-1076.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
66. Cardno AG, Sham PC, Murray RM, McGuffin P. Twin study of symptom dimensions in psychoses. Br J Psychiatry. 2001;179:39-45.
FREE FULL TEXT
67. Van Os J, Marcelis M, Sham P, Jones P, Gilvarry K, Murray R. Psychopathological syndromes and familial morbid risk of psychosis [see comments]. Br J Psychiatry. 1997;170:241-246.
FREE FULL TEXT
68. Rietkerk T, Boks MP, Sommer IE, Liddle PF, Ophoff RA, Kahn RS. The genetics of symptom dimensions of schizophrenia: review and meta-analysis. Schizophr Res. 2008;102(1-3):197-205.
WEB OF SCIENCE
| PUBMED
69. Vassos E, Sham PC, Cai G, Deng H, Liu X, Sun X, Zhao J, Murray RM, Collier DA, Li T. Correlation and familial aggregation of dimensions of psychosis in affected sibling pairs from China. Br J Psychiatry. 2008;193(4):305-310.
FREE FULL TEXT
70. Carpenter WT Jr, Heinrichs DW, Wagman AM. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry. 1988;145(5):578-583.
WEB OF SCIENCE
| PUBMED
71. Kirkpatrick B, Castle D, Murray RM, Carpenter WT Jr. Risk factors for the deficit syndrome of schizophrenia. Schizophr Bull. 2000;26(1):233-242.
FREE FULL TEXT
72. Loftus J, Delisi LE, Crow TJ. Factor structure and familiality of first-rank symptoms in sibling pairs with schizophrenia and schizoaffective disorder. Br J Psychiatry. 2000;177:15-19.
FREE FULL TEXT
73. Cardno AG, Sham PC, Farmer AE, Murray RM, McGuffin P. Heritability of Schneider's first-rank symptoms. Br J Psychiatry. 2002;180:35-38.
FREE FULL TEXT
74. Malaspina D, Corcoran C, Fahim C, Berman A, Harkavy-Friedman J, Yale S, Goetz D, Goetz R, Harlap S, Gorman J. Paternal age and sporadic schizophrenia: evidence for de novo mutations. Am J Med Genet. 2002;114(3):299-303.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
75. McClellan JM, Susser E, King MC. Schizophrenia: a common disease caused by multiple rare alleles. Br J Psychiatry. 2007;190:194-199.
FREE FULL TEXT
76. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, Stray SM, Rippey CF, Roccanova P, Makarov V, Lakshmi B, Findling RL, Sikich L, Stromberg T, Merriman B, Gogtay N, Butler P, Eckstrand K, Noory L, Gochman P, Long R, Chen Z, Davis S, Baker C, Eichler EE, Meltzer PS, Nelson SF, Singleton AB, Lee MK, Rapoport JL, King MC, Sebat J. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 2008;320(5875):539-543.
FREE FULL TEXT
77. Xu B, Roos JL, Levy S, van Rensburg EJ, Gogos JA, Karayiorgou M. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet. 2008;40(7):880-885.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
78. Jang KL, Livesley WJ, Vernon PA. Heritability of the big five personality dimensions and their facets: a twin study. J Pers. 1996;64(3):577-591.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
79. Schmael C, Georgi A, Krumm B, Buerger C, Deschner M, Nöthen MM, Schulze TG, Rietschel M. Premorbid adjustment in schizophrenia–an important aspect of phenotype definition. Schizophr Res. 2007;92(1-3):50-62.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
80. Hallmayer JF, Kalaydjieva L, Badcock J, Dragovic M, Howell S, Michie PT, Rock D, Vile D, Williams R, Corder EH, Hollingsworth K, Jablensky A. Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit. Am J Hum Genet. 2005;77(3):468-476.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
81. Gur RE, Calkins ME, Gur RC, Horan WP, Nuechterlein KH, Seidman LJ, Stone WS. The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes. Schizophr Bull. 2007;33(1):49-68.
FREE FULL TEXT
82. Gur RE, Nimgaonkar VL, Almasy L, Calkins ME, Ragland JD, Pogue-Geile MF, Kanes S, Blangero J, Gur RC. Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia. Am J Psychiatry. 2007;164(5):813-819.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
83. Greenwood TA, Braff DL, Light GA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Mintz J, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Schork NJ. Initial heritability analyses of endophenotypic measures for schizophrenia: the Consortium on the Genetics of Schizophrenia. Arch Gen Psychiatry. 2007;64(11):1242-1250.
FREE FULL TEXT
84. Wainwright MA, Wright MJ, Geffen GM, Luciano M, Martin NG. The genetic basis of academic achievement on the Queensland Core Skills Test and its shared genetic variance with IQ. Behav Genet. 2005;35(2):133-145.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
85. Owens DG, Johnstone EC. Precursors and prodromata of schizophrenia: findings from the Edinburgh High Risk Study and their literature context. Psychol Med. 2006;36(11):1501-1514.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
86. Bilder RM, Reiter G, Bates J, Lencz T, Szeszko P, Goldman RS, Robinson D, Lieberman JA, Kane JM. Cognitive development in schizophrenia: follow-back from the first episode. J Clin Exp Neuropsychol. 2006;28(2):270-282.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
87. MacCabe JH, Aldouri E, Fahy TA, Sham PC, Murray RM. Do schizophrenic patients who managed to get to university have a non-developmental form of illness? Psychol Med. 2002;32(3):535-544.
WEB OF SCIENCE
| PUBMED
88. McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness: development and reliability of the OPCRIT system. Arch Gen Psychiatry. 1991;48(8):764-770.
FREE FULL TEXT
89. MacCabe JH, Lambe MP, Cnattingius S, Torrang A, Bjork C, Sham PC, David AS, Murray RM, Hultman CM. Scholastic achievement at age 16 and risk of schizophrenia and other psychoses: a national cohort study. Psychol Med. 2008;38(8):1133-1140.
WEB OF SCIENCE
| PUBMED
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
RELATED ARTICLE
This Month in Archives of General Psychiatry
Arch Gen Psychiatry. 2009;66(6):579.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Impairment in Functional Capacity as an Endophenotype Candidate in Severe Mental Illness
Harvey et al.
Schizophr Bull 2011;0:sbr046v1-sbr046.
ABSTRACT
| FULL TEXT
Kraepelin Was Right: A Latent Class Analysis of Symptom Dimensions in Patients and Controls
Derks et al.
Schizophr Bull 2010;0:sbq103v2-sbq103.
ABSTRACT
| FULL TEXT
|